Thyme and neural pathways symbolizing natural treatment of MS.

Unlock Natural Relief: Can Thyme Combat Multiple Sclerosis?

Jordan Keane monogram
Jordan Keane in Health & Wellness October 2026 • 4 min read.

"Discover how Thymus vulgaris extract could revolutionize autoimmune disease treatment, offering new hope for those battling experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)."


Multiple sclerosis (MS) is a debilitating chronic neurodegenerative disease affecting millions worldwide. This condition attacks the central nervous system (CNS), leading to a range of neurological disabilities as myelin, axons, and oligodendrocytes suffer damage. Finding effective treatments that minimize side effects remains a significant challenge.

In the quest for alternative therapies, researchers have increasingly turned to natural compounds. Thymus vulgaris, commonly known as thyme, has a rich history in traditional medicine, celebrated for its antimicrobial, antioxidant, and anti-inflammatory properties. This has sparked interest in its potential to alleviate symptoms of autoimmune diseases like MS.

A groundbreaking study has explored the effects of Thymus vulgaris extract on experimental autoimmune encephalomyelitis (EAE), an animal model for MS. The findings reveal promising results, highlighting thyme's ability to modulate clinical symptoms, reduce histopathological scores, and influence the production of key cytokines involved in the disease process. This article delves into these exciting discoveries, offering new hope for natural MS treatments.

AI Search Multiple angles on this topic

MS and Complementary Care

Multiple sclerosis is a chronic autoimmune disease of the central nervous system that commonly begins in young adulthood. In MS, inflammatory cells damage the myelin sheath, while genetic and environmental factors may influence disease initiation or progression. Many people with MS explore complementary approaches to help manage relapses or symptoms including pain, muscle spasticity, fatigue, cognition, and depression.

Evidence and Limits

People with MS may use complementary health approaches alongside medical care to address symptoms such as pain, spasticity, fatigue, cognition, and depression. The NCCIH reports that practices such as yoga may ease some MS symptoms, but definitive evidence remains lacking for complementary approaches as treatments that alter the disease itself. The American Academy of Neurology's guideline, reaffirmed on February 21, 2026, was developed to provide evidence-based recommendations for complementary and alternative medicine in MS.

From Recognition to Treatment

Historical accounts describe observations resembling MS before the disease was formally framed and named by Jean-Martin Charcot in 1868. Later progress included improved descriptions of the disease, classification of clinical types, development of diagnostic tests, and advances in treatment. The history of treatment includes the approval of the first disease-modifying therapy and subsequent breakthroughs documented in modern milestone timelines.

Thyme's Impact on EAE: A Deep Dive into the Research

Thyme and neural pathways symbolizing natural treatment of MS.

The study, detailed in Biomedicine & Pharmacotherapy, investigated the effects of Thymus vulgaris extract on mice with induced EAE. Researchers administered thyme extract at varying doses and monitored several key indicators, including clinical symptoms, histopathological changes, and cytokine production.

Here's a breakdown of the study's methodology:

  • EAE Induction: EAE was induced in mice using the MOG35-55 peptide.
  • Treatment: Mice were treated with either phosphate-buffered saline (PBS) as a control or thyme extract (50 or 100 mg/kg) every other day for 21 days.
  • Evaluation: The researchers assessed clinical symptoms, histopathological scores in the central nervous system (CNS), and the production of various cytokines.
  • Cytokine Analysis: Splenocytes (immune cells from the spleen) were isolated and stimulated to measure the production of pro-inflammatory (IFN-γ, IL-6, IL-17) and anti-inflammatory (TGF-β, IL-4, IL-10) cytokines.
AI Search Multiple angles on this topic

Current MS Research

Recent reviews describe MS as a chronic autoimmune disorder involving immune-driven demyelination and neurodegeneration in the central nervous system. Current research examines the disease's etiology, clinical features, pathology, therapeutic approaches, and molecular mechanisms. One 2025 review highlights T- and B-cell involvement, dysregulated TGF-beta, Akt, and Wnt signaling, and the role of cell death in disease progression.

Limits of Natural Cures

A 2026 review of complementary therapies emphasizes the need to organize clinical research so it can support clinical decisions and guide future studies. Separately, a review of natural approaches reports that there is no natural cure for MS and that no treatment, whether natural or pharmaceutical, can permanently eliminate the disease. These points argue against presenting thyme or another supplement as a proven replacement for disease-modifying treatment.

CAM Use and Evidence

Complementary and alternative medicine therapies have been suggested for managing MS symptoms, but studies of their efficacy and safety are described as very limited. A study conducted in California and Massachusetts reported that 60% of patients with MS used CAM, with each person using two or three different forms. High use therefore does not by itself establish that any particular therapy, including thyme, is effective or safe.

The results revealed a significant reduction in clinical symptoms and histopathological scores in the thyme-treated groups compared to the control group. Furthermore, thyme extract modulated cytokine production, reducing pro-inflammatory markers and boosting anti-inflammatory ones. This suggests that thyme vulgaris can indeed influence the immune response in EAE.

The Future of Thyme in Autoimmune Disease Management

This study opens exciting new avenues for exploring Thymus vulgaris as a potential therapy for MS and other autoimmune conditions. While further research is needed to fully understand the mechanisms of action and optimal dosages, the findings suggest that thyme extract could offer a safe, natural, and effective way to manage symptoms and improve the quality of life for those affected by these challenging diseases.

AI Search Multiple angles on this topic

Natural Products and Remyelination

MS involves inflammation, demyelination, and axonal injury, and currently available medications do not directly promote repair of the myelin sheath. This limitation has led researchers to investigate natural products as potential therapeutic agents, including approaches intended to promote remyelination. However, broader reviews note that despite extensive CAM use in MS, comprehensive evidence is still needed to evaluate its role in symptom management.

Biomarkers and Better Treatments

Biomarkers are expected to become an important part of future MS research and treatment development. Current disease-modifying therapies largely work by modulating or suppressing the immune system's attack on nerves in the central nervous system. Future research may therefore focus on identifying more precise disease markers and developing treatments guided by those markers.

A Complex Disease

MS is a complex neurological condition whose symptoms and progression can vary substantially between individuals. This variability makes it difficult to generalize results from limited studies of natural or complementary therapies. Any broader discussion of thyme should therefore distinguish preliminary possibilities from clinically established treatment.

Living With Uncertainty

People with MS may seek complementary options because symptoms can affect daily life in varied and unpredictable ways. Interest in natural relief can reflect a desire to manage symptoms while navigating the limits and burdens of existing treatment. Such choices are best considered cautiously, with attention to evidence, safety, and ongoing medical care.

What an EAE mouse study can establish

Animal study (level 5 of 8)

This animal study can show how thyme extract related to measured outcomes in mice with EAE, but it cannot establish that the same effects occur in people with MS.[1]

The experiment followed mice through the treatment period and assessed cytokines after their splenocytes were restimulated in vitro, so those measurements describe this model and laboratory setup.[1]

What the measured changes suggest

The reported pattern points to a shift in immune activity alongside lower clinical and CNS tissue scores in treated EAE mice; it does not show that thyme treats human MS.[1]

Because the cytokines were measured in stimulated spleen cells, the result concerns an immune response measured outside the animal rather than a demonstrated change in human disease.[1]

Where the mouse findings are weakest

  • The authors describe thyme's possible relevance to MS as a subject for future study, not an established therapy.[1]

Thyme extract tested in MOG-induced EAE mice

Study designAnimal study[1]
PopulationMice with EAE[1]
DurationFrom day 0 to +21 of post MOG immunization; mice were sacrificed at day 22[1]
ComparisonEAE control group treated with phosphate buffered saline (PBS)[1]
Main outcomeClinical symptoms, histopathological scores, and cytokine production[1]
Effect sizeClinical symptoms, histopathological scores, IFN-γ and IL-6 production were lower, while IL-10 and TGF-β production increased in thyme-treated mice compared with controls[1]
Times cited31[1]

Questions the experiment leaves open

  • How do the cytokine changes relate to disease processes that this EAE model does not represent well, including myelin damage and repair?[1] [2]

Terms used in the study

EAE
Experimental autoimmune encephalomyelitis[3]

Sources

  1. Beneficial effects of Thymus vulgaris extract in experimental autoimmune encephalomyelitis: Clinical, histological and cytokine alterations (Elsevier BV, 2019)
  2. Which experimental factors govern successful animal-to-human translation in multiple sclerosis drug development? A systematic review and meta-analysis (pmc.ncbi.nlm.nih.gov)
  3. Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.biopha.2018.08.078, Alternate LINK

Title: Beneficial Effects Of Thymus Vulgaris Extract In Experimental Autoimmune Encephalomyelitis: Clinical, Histological And Cytokine Alterations

Subject: Pharmacology

Journal: Biomedicine & Pharmacotherapy

Publisher: Elsevier BV

Authors: Merat Mahmoodi, Fatemeh Ayoobi, Azita Aghaei, Mehdi Rahmani, Zahra Taghipour, Azar Hosseini, Abdollah Jafarzadeh, Mojtaba Sankian

Published: 2019-01-01

Everything You Need To Know

1

How does Multiple Sclerosis (MS) affect the body, and what makes finding effective treatments so difficult?

Multiple Sclerosis (MS) is a chronic neurodegenerative disease where the central nervous system (CNS) is attacked. This leads to damage of myelin, axons, and oligodendrocytes, resulting in a range of neurological disabilities. Finding effective treatments is challenging because current options often come with significant side effects, and managing the complex immune responses involved in the disease is difficult. Further research into targeted therapies is needed to minimize damage and promote regeneration in the CNS. Other treatment options can include addressing the gut-brain axis or gene editing therapies to address the root cause of MS.

2

What is Thymus vulgaris, and what properties make it a candidate for autoimmune disease treatment?

Thymus vulgaris, commonly known as thyme, is a herb traditionally recognized for its antimicrobial, antioxidant, and anti-inflammatory properties. These characteristics have led to investigations into its potential to alleviate symptoms of autoimmune diseases. Its ability to modulate the immune response and reduce inflammation makes it a promising natural alternative for managing conditions like Multiple Sclerosis (MS). It is important to note that the extract used in the study underwent testing to concentrate the effective elements while eliminating toxins. This makes the extract different than consuming the herb directly.

3

What is experimental autoimmune encephalomyelitis (EAE), and why is it relevant in Multiple Sclerosis (MS) research?

Experimental autoimmune encephalomyelitis (EAE) is an animal model used to study Multiple Sclerosis (MS). Researchers use EAE in mice to mimic the symptoms and progression of MS in humans. Studying Thymus vulgaris extract's effects on EAE helps scientists understand how it might influence the disease process in MS, including its impact on clinical symptoms, histopathological changes, and cytokine production. Since MS is a human specific disease it's important to understand the limitations of EAE when applying results directly. For example, the blood-brain barrier structure and the types of immune cells involved might differ.

4

In the study, how did Thymus vulgaris extract impact the production of cytokines in mice with experimental autoimmune encephalomyelitis (EAE)?

In the EAE study, Thymus vulgaris extract modulated cytokine production in mice. Specifically, it reduced the levels of pro-inflammatory cytokines such as IFN-γ, IL-6, and IL-17, while boosting the production of anti-inflammatory cytokines like TGF-β, IL-4, and IL-10. This shift in cytokine balance suggests that thyme vulgaris can influence the immune response, reducing inflammation and potentially alleviating symptoms of autoimmune diseases. It is important to understand other inflammatory and regulatory signals beyond cytokines. For example, chemokines also play a significant role in immune cell trafficking and activation within the CNS during EAE and MS.

5

What are the implications of the Thymus vulgaris extract study for future Multiple Sclerosis (MS) treatments, and what further research is needed?

The Thymus vulgaris extract study suggests that it could be a potential therapy for Multiple Sclerosis (MS) and other autoimmune conditions. The extract's ability to modulate clinical symptoms, reduce histopathological scores, and influence cytokine production opens new avenues for natural MS treatments. Further research is needed to fully understand the mechanisms of action, determine optimal dosages, and assess long-term safety and efficacy. Clinical trials involving human subjects would be crucial to validate these findings and explore the potential of thyme extract as a safe, natural, and effective way to manage symptoms and improve the quality of life for those affected by MS.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.